Primary Acquired Nasolacrimal Duct Obstruction
4
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
8 treatments under study, led by External Dacryocystorhinostomy
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
External Versus Powered Endoscopic Dacryocystorhinostomy With Mitomycin C for Primary Acquired Nasolacrimal Duct Obstruction
Comparative Outcomes of Four Versus Two Balloon Inflation Points in Dacryoplasty for Primary Acquired Nasolacrimal Duct Obstruction
Efficacy Evaluation of 5-Fluorouracil as an Adjuvant to Endoscopic Dacryocystorhinostomy in Managing Primary Acquired Nasolacrimal Duct Obstruction With Small Lacrimal Sac: A Randomized Controlled Study
External DCR Versus Canalicular SI With MMC in NLDO
Research Network
Common Treatments
- External Dacryocystorhinostomy2
- Fluorouracil1
- 4 Point Balloon Dacryoplasty With Lacricath1
- Mitomycin1
- Saline Group1
Active Sponsors
- Military Institute od Medicine National Research Institute1
- National Taiwan University Hospital1
- Menoufia University1
- Zhongshan Ophthalmic Center, Sun Yat-sen University1
Top Investigators
National Taiwan University Hospital